Search

Abbott Laboratories

Suletud

SektorTervishoid

104.87 1.41

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

102.95

Max

105.19

Põhinäitajad

By Trading Economics

Sissetulek

-149M

928M

Müük

1.4B

13B

P/E

Sektori keskmine

33.786

49.241

Aktsiakasum

1.31

Dividenditootlus

2.36

Kasumimarginaal

7.369

Töötajad

122,000

EBITDA

548M

2.8B

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+17.76% upside

Dividendid

By Acuity

Dividenditootlus

Sektori keskmine

2.36%

2.15%

Järgmine tulemuste avaldamine

21. jaan 2027

Järgmine dividendimakse kuupäev

16. nov 2026

Järgmine aktsia dividendi kuupäev (ex-date)

14. jaan 2027

Turustatistika

By TradingEconomics

Turukapital

16B

180B

Eelmine avamishind

103.46

Eelmine sulgemishind

104.87

Abbott Laboratories Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. okt 2026, 23:01 UTC

Abbott Laboratories shares are trading modestly lower in after-market hours, experiencing notable volatility after shifting from slight gains to losses.

22. okt 2026, 23:51 UTC

Abbott Laboratories is gaining modestly in after-market trading, positioned significantly above its 20-day moving average and nearing the upper end of its one-month trading range.

21. okt 2026, 23:06 UTC

Abbott Laboratories shares are trading slightly higher in after-market hours, amid broader equity gains following a significant decline in U.S. crude oil inventories.

20. okt 2026, 23:01 UTC

Abbott Laboratories shares are trading lower in after-market hours, continuing a downward trend amid broader weakness in the Health Care Equipment sub-sector.

19. okt 2026, 23:41 UTC

Abbott Laboratories shares are trading modestly lower in after-market hours after retracing from an early peak above Monday's close.

17. okt 2026, 00:01 UTC

Abbott Laboratories is trading modestly lower in after-market hours, retracing from a brief uptick earlier.

16. okt 2026, 23:01 UTC

Abbott Laboratories shares are trading modestly lower in after-market hours, following a brief rise earlier, amid ongoing volatility.

15. okt 2026, 23:06 UTC

Abbott Laboratories is trading lower in after-market hours, with cumulative returns dipping below Thursday's close after fluctuating during the session.

14. okt 2026, 23:31 UTC

Abbott Laboratories shares advanced in after-market trading, reflecting strength as they trade above their 20-day moving average and near the upper end of their one-month range.

13. okt 2026, 20:08 UTC

Abbott Laboratories shares advanced, closing modestly above Monday's close, despite pulling back from an early session high during Tuesday's trading.

12. okt 2026, 23:06 UTC

Abbott Laboratories is trading higher in after-market hours, continuing a trend of three consecutive daily closes with slight upward movement since Monday's close.

10. okt 2026, 00:01 UTC

Abbott Laboratories is trading higher in after-market hours, marking the highest cumulative return since Friday's close and showing unusual strength within its one-month range.

9. okt 2026, 22:01 UTC

Abbott Laboratories shares advanced in after-market trading, reflecting a modest increase since Friday's close while fluctuating around the middle of its one-month range.

8. okt 2026, 22:45 UTC

Abbott Laboratories shares are trading lower in after-market hours, remaining below their 20-day moving average and near the lower end of their one-month range.

7. okt 2026, 23:50 UTC

Abbott Laboratories is trading slightly higher in after-market hours, following a modest earlier session increase, though it remains below its 20-day moving average.

6. okt 2026, 20:07 UTC

Abbott Laboratories shares fell sharply after an earlier rise, reaching their lowest point of the day and remaining below the 20-day moving average.

5. okt 2026, 23:05 UTC

Abbott Laboratories is trading slightly higher in after-market hours, while the S&P Global Composite PMI rose to 58.4, indicating strong growth in the U.S. economy.

2. okt 2026, 20:07 UTC

Social Media
News

Abbott Laboratories upgraded to Buy from Hold by Rothschild & Co Redburn, with a price target increase to $127, as shares trade modestly higher.

1. okt 2026, 20:07 UTC

Abbott Laboratories shares fell sharply, closing at their lowest point for the session and trading well below the 20-day moving average.

30. sept 2026, 20:07 UTC

News

Abbott Laboratories launched SimpleScreen CRC, an FDA-approved blood test for colorectal cancer, but shares fell amid broader market trends.

29. sept 2026, 23:00 UTC

Abbott Laboratories is declining in after-market trading, finishing lower for three consecutive sessions and positioned significantly below its 20-day moving average.

25. sept 2026, 20:07 UTC

Abbott Laboratories' shares are higher amid a broader market rally, recovering from an earlier pullback but still below its 20-day moving average.

24. sept 2026, 19:51 UTC

Macro Event

Abbott Laboratories shares fell, diverging from recent gains, amid a report showing a slight improvement in U.S. Jobless Claims' 4-week Average.

23. sept 2026, 20:01 UTC

News

Abbott Laboratories announced a partnership with Berry Street for personalized nutrition support, but shares fell amid broader market reactions to insider trading activity.

22. sept 2026, 23:41 UTC

Abbott Laboratories is seeing a modest increase in after-market trading, following three consecutive higher daily closes despite being below its 20-day moving average.

21. sept 2026, 23:00 UTC

Abbott Laboratories is trading modestly higher in after-market hours, recovering from earlier declines but remains below its 20-day moving average.

16. sept 2026, 19:16 UTC

Abbott Laboratories shares are modestly higher but remain below their 20-day moving average and near the lower end of their one-month range.

15. sept 2026, 23:01 UTC

Abbott Laboratories shares are higher in after-market hours, reflecting broader market trends. No specific company news was identified to explain the movement.

14. sept 2026, 22:51 UTC

Abbott Laboratories shares are lower in after-market hours, reflecting broader market declines amid rising crude oil prices due to geopolitical supply concerns.

12. sept 2026, 00:01 UTC

Abbott Laboratories shares are higher in after-market trading, despite being below the 20-day moving average and a trend of lower closes.

Võrdlus sarnastega

Hinnamuutus

Abbott Laboratories Prognoos

Hinnasiht

By TipRanks

17.76% tõus

12 kuu keskmine prognoos

Keskmine 122.118 USD  17.76%

Kõrge 135 USD

Madal 115 USD

Põhineb 19 Wall Streeti analüütiku instrumendi Abbott Laboratories 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

19 ratings

18

Osta

1

Hoia

0

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
help-icon Live chat